Next Article in Journal
β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells
Previous Article in Journal
Correction: Kazmi et al. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021, 13, 2086
Previous Article in Special Issue
New Peptide Based Fluconazole Conjugates with Expanded Molecular Targets
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(4), 881; https://doi.org/10.3390/pharmaceutics14040881
Action Date Notes Link
article xml file uploaded 18 April 2022 12:14 CEST Original file -
article xml uploaded. 18 April 2022 12:14 CEST Update https://www.mdpi.com/1999-4923/14/4/881/xml
article pdf uploaded. 18 April 2022 12:14 CEST Version of Record https://www.mdpi.com/1999-4923/14/4/881/pdf
article supplementary file uploaded. 18 April 2022 12:14 CEST - https://www.mdpi.com/1999-4923/14/4/881#supplementary
article html file updated 18 April 2022 12:16 CEST Original file -
article html file updated 2 August 2022 19:28 CEST Update https://www.mdpi.com/1999-4923/14/4/881/html
Back to TopTop